Home » Market News » DirectorsTalk Highlights » CBD analysis in UK finds high THC levels & other problems

CBD analysis in UK finds high THC levels & other problems

Almost half of 30 CBD products being sold in the UK recently tested hot for THC, recording double the generally accepted standard of 0.2% across Europe.

The study, published this month, was carried out by analysts PhytoVista under commission from the UK’s Centre for Medical Cannabis (CMC), an industry trade group.

Gathering products available both online and at retail outlets, PhytoVista reported that 45% of those tested had levels of THC with a mean content 0.4%.

Sativa Group PLC (NEX:SATI) is a seed to consumer medicinal cannabis and cannabidiol (CBD) wellness business, focused on the smart-sourcing of the raw material, advanced extraction, manufacture, testing, distribution, and research & development of medicinal cannabis and CBD products.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.